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Metabolic Bone Disease in Chronic Renal Failure 
II. Renal Transplant Patients 
W. E. Huffer, MD, D. Kuzela, MD, M. M. Popovtzer, MD 
and T. E. Starzl, MD 
Trabecular vertebral bone of renal transplant patients was quantitatively compared 
with bone from normal individuals and dialyzed and non dialyzed patients with. 
chronic renal failure reported in detail in an earlier study. Long- and short-term 
transplant patients havc increased bone resorption and mineralization defects 
similar to rennl osteodystrophy in dialyzed and non dialyzed patients. However, 
in transplant patients the magnitude of resorption is greater, and bone volumle 
tends to decrease rather than increase. Resorptive activity in transplant patients 
is maximal during the Srst year after transplantation. BOlle volume decreases 
continuously for at least 96 months after transplantation. Only decreased bOllle 
volume correlated with suecess or failw'e of the renal transplant. MOrr>hologic 
findings ill fhis study correlate with other clinical and morphologic data to suggest 
that reductio1l in ho;.e volume in transplant patients results from a combination 
of persistent hyperparathyroidism and suppression of bone formation by steroid 
therapy. (Am J PathoI 78:385-400, 1975). 
A PREVIOUS STUDY from this institution substantiated the re-
sults of earlier papers which showed that persistent metabolic bone 
disease closely resembling conventional renal osteodysh'ophy remains 
a significant obstacle to complete rehabilitation of patients with chronic 
renal failure treated by maiutenance hemodialysis.1 The study showed 
that bone disease in dialysis patients did not improve significantly be-
bveen 1966 and 1972. 
Persistent metabolic bone disease in patients with chronic renal 
failure treated by renal transplantation is a less severe clinical problemK:~ 
Some transplant patients, however, have debilitative bone disease 3,'1 
which is explainable in part by lesions characteristic of conventional 
renal osteodystrophy and dialysis bone discase.2.4 
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No systematic histomorphologic study defining the relationship of 
transplant bone disease to metabolic bone disease in dialyzed and non-
dialyzed patients has been reported. Most of the studies of bone disease 
in transplant patients have focused on aseptic necrosis and steroid-
induced osteoporosis H without first defining the relationship between 
these diseases and renal osteodystrophy and dialysis bone disease. The 
relationship is Significant since most patients receiving transplants will 
have some form of renal osteodystrophy 2 and many will have been 
treated by maintenance dialysis. In addition, some workers feel that 
aseptic necrosis can result from fractures in bones \veakened by osteo-
porosis.7 It is appropriate to ask, therefore, whether the osteoporosis 
seen in transplant patients is similar. to other forms of osteoporosis, or 
whether it is more closely related to lesions of renal osteodystrophy 
and dialysis bone I disease. 
Preliminary studies from Hammersmith Hospital have indicated that 
bone lesions characteristic of renal osteodystrophy regress after renal 
transplantation, with the most marked improvement in patients with 
better than average renal function.s Histologic improvement was said 
to continue, providing renal function did not deteriorate. The bones of 
some patients, however, were adversely affected by steroids. 
In contrast, preliminary shldies from this institution showed severe 
resorptive bone lesions in 6 long-term transplant patients with good 
renal function but "ith clinical evidence of hyperparathyroidism.1l The 
bone lesions were thought to represent persistent osteitis fibrosa modified 
by steroid therapy. The findings and conclusions are compatible with 
other clinical studies indicating that hyperparathyroidism frequently 
persists in both short-term 2 and long-term 10 transplant patients. 
Since the results cited above suggested that reduced bone volume 
( osteoporosis) in transplant patients was related to persistence of one 
fonn of renal osteodystrophy, secondary hyperparathyroidism, it seemed 
appropriate to determine whether other lesions characteristic of renal 
osteodystrophy persist in transplant patients. The study reported here 
was designed to answer that question, to provide further information 
about the pathogenesis of osteoporosis in renal transplant patients, and 
to provide further data about the relationship between success or failure 
of renal transplants and the severity and types of metabolic bone lesions. 
Materials and Methods 
Sections of trabecular vertebral bone obtained at autopsy from 18 short-telm 
«6 months) and 17 long-term (>6 months) transplant patients were processed 
for microscopic examination by methods previously described. t Data obtained by 
a modification of Gamer and Ball's point-counting method 11 was used to calculate 
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the relative total bone volume (BV), calci£ed bone volume (Ca" BV), osteoid 
index (01), resorption volume (RV), resorptive index (RI) and volume to sUiface 
ratio (V:S) of all sections by formulae given in the previous publication. 1 Semi-
quantitative resorp"tion grades from 0 to 4 were also asSigned to each section using 
histologic criteria previously defined.! To facilitate comparison between bone from 
transplant patients and that from dialyzed and non dialyzed patients, some of the 
data in the pre-eeding publication is reported here. Statistical methods have been 
described previously.l 
Results 
Resorptive Activity and Distortion of Trabecular Architecture 
All transplant patients had increased resorptive activity as judged by 
semiquantitative grading (Text-figure 1). There was no significant 
difference in the percentage of individuals with Grade 1 to 4 resorption 
between long- and short-term transplant patients. The most Significant 
difference between transplant patients and dialyzed and non dialyzed 
patients was the exclusive occurrence of Grade 4 lesions in the trans-
plant group. These lesions were characterized by extreme loss of volume 
in the majority of trabeculae by a process of internal tunneling resorp·· 
tion as illustrated in Figure 1. The lesions were distinguished from 
Similarly extensive tunneling resorption in primary h) -perparathyroidism 
Short Long 
Transplant Transplant 
Resorption Grade 
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by their lack of significant marrow fibrosis and relative lack of seconcary 
bone formation; they were distinguished from tunneling resorption seen 
in secondary hyperparathyroidism I[)f dialyzed and nondialyzed patients 
because in those individuals marrow fibrosis and bone formation was 
more prominent, the proportion of resorptive space to total trabecular 
volume (RI) was less, and the ratio of trabecular volume to trabecular 
surface (V:S ratio) was greater (see below). 
The relative intratrabecular volume resulting from bone resorption 
(resorption volume) was markedly increased in transplant patients 
(Table 1). The mean resorptive volume of all transplant patients was 
significantly greater than that of normal individuals (P < .005) and was 
slightly greater than the mean of non dialyzed and dialyzed patients. The 
mean resorption volume of short-tenn transplant patients was almost two 
times greater than the means of nondialyzed and dialyzed patients and 
of long-term transplant patients (P < .005). 
The ratio of intra trabecular resorption volume to total bone volume 
(resorptive index) was also greater in the transplant group than it was 
in the nondialyzed and dialyzed groups (Table 1). However, there was 
little difference in mean resorptive indices (RI) between long- and 
short-term h'ansplant patients. 
The volume to surface ratio (V: S) measured both resorptive activity 
and degree of trabecular distortion. V:S ratio of short-term transplant 
patients was similar to that of dialyzed patients. The mean V:S ratio 
of long-term transplant patients, however, was apprOXimately one-half 
that of the other renal disease groups (Table 1). 
The percentages of individuals in each renal disease group with 
specified deviations from normal mean values of RI and V: S are illus-
trated in Text-figure 2. The overall distribution of RI values was similar 
in both of the transplant groups and the long-term dialysis patients. 
The distribution of V:S ratios in short-term transplant patients was aho 
similar to the distribution in long-tenn dialysis patients. However, the 
distribution with respect to this parameter in the long-term transplant 
group was markedly different from any other group; most of the indidd-
nals fen in the range from one-fifth to three-fifths normal. 
Changes in Bone Volume 
Mean values for bone volume of the total transplant group or of the 
short-term transplant group did not differ Significantly from normal or 
from the dialyzed or non dialyzed uremic groups (Table 1). However, 
the mean value of the long-term transplant group was significantly 
lower than all other groups (P < .005). The djstribution of individuals 
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icantly less than the mean for long-term dialysiS patients (P < .005). 
The distribution of individuals with specified ranges of osteoid index 
was approximately the same in long- and short-term transplant groups, 
both of which were comparable to short-term dialysis patients. 
Interrelationships Among Different Indices of Bone Histology 
and the Duration of Transplantation 
There was no statistically significant relationship between osteoid 
index and any other index of bone histology, or between osteoid index 
and duration of transplantation. Stated differently, both the osteoid and 
the calcified hone volumes changed in the same ,yay as the total bone 
volume changed. 
As noted previously, the absolute amount of resorptive volume was 
marimal in short-term transplant patients and was somewhat decreased 
in long-tenn transplant patients. The resorptive index was approximately 
the same in long- and short-term transplant patients. There was, how-
ever, no statistically significant linear correlation between these two 
indices and duration of transplantation. 
There was no linear correlation between V:S ratio and duration of 
traJ.lsplantation for the entire transplant group (0.2 to 96 months). 
However, from 0.2 to 12 months there was a Significant (P < .005) 
decrease in V: S ratio, and from 12 to 96 months an equally Significant 
but markedly less steep increase in the V: S ratio (Text-figure 3). 
As noted above, bone volume in long-term transplant patients tended 
to be lower than the bone volume in short-term transplant patients. 
There was a statistically Significant decrease in bone volume from 0.2 
to 96 months (Text-figure 4). 
TEXT-FIG 3-Regression analysis of 
V: S ratio as a function of transplant 
duration. There is a strong negative 
slope between 0 to 13 months 
(- 0.38 v: S units/mon, P < .005) 
and a slight positive slope from 12 
to 96 months (+ .017 V:S units/mon, 
P < .005). 
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TEXT-FIG 4-Regression analysis of 
total bone volume as a function of 
transplant duration. There is a slight 
negative slope (- 0.07%/mon, P < 
.005). 
Relationship Between Transplant Rejection and Quantitative Bone Histology 
Tables 2 and 3 compare indices of bone histology in transplant pa-
tients with good and bad renal function. Individuals in Group A had 
no clinical evidence of rejection or had rejection of less than 2 months. 
Individuals in Group B had clinical evidence of rejection during the 
entire period of transplantation. The osteoid index, resorptive volume, 
and volume to surface ratio of the transplant patients with good renal 
function did not differ Significantly from those of patients with poor 
renal function follOWing transplantation. The duration of transplantation 
for 8 of the 10 patients \vith good renal function was 4 months or less. 
The only Significant difference in bone histology between the two groups 
was a decrease in bone volume in the patients with rejection (P .05 to 
.025). Individuals in Group C all had long-term transplants, but there 
were marked differences in the duration of rejection between individ-
uals with the same total transplant duration. There were no consistent 
differences in any of the quantitative indices of bone histology between 
such individuals. 
Discussion 
The results of this study do not fully support the experience of 
Hammersmith Hospital. S Both long- and short-term transplant patients 
at this institution have many of the features of renal osteodystrophy. 
As a group, transplant patients have more severe bone resorption than 
either nondialyzed or dialyzed patients. They also have mineralization 
defects which in terms of relative incidence and severity are more severe 
than those of nondial;'zed patients, about the same as those of short-
term dialysis patients, and less severe than those of long-term dialysis 
patients. 
Metabolic bone disease in transplant patients here differs from that 
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Table 3-Quantitative Bone Histology and Transplant Function in Long-Term Transplants 
(Group C) 
Total 
transplant 
duration Poor Good 
Case No. (mon) function function 01 RV BV V:S RG-
69-401 12 12 0 .038 .003 .130 1.7 4 
70-52 12 1 11 .032 .023 .153 1.5 4 
71-254 12 12 0 .022 .003 .119 1.2 1 
72-166 12 2 10 .000 .000 .078 1.9 1 
69-255 24 24 a .000 .002 .097 3.6 3 
69-265 24 12 12 .004 .000 .089 2.4 2 
69-283 24 6 18 .045 .003 .078 1.3 4 
72-87 24 12 12 .013 .000 .126 2.8 2 
72-232 36 12 24 .000 .003 .132 4.1 2 
72-235 36 12 24 .072 .001 .082 1.8 2 
60-351 48 12 36 .125 .008 .050 1.3 4 
72-254 54 24 30 .042 .025 .109 1.4 4 
69-111 72 12 60 .199 .000 .090 2.5 3 
.. Resorptive grade. 
seen in dialyzed and nondialyzed uremics in one important aspect: 
Transplant patients do not have increased bone volume but rather a 
very strong tendency toward a decreased bone volume. The opposite 
situation tends to prevail in the other two groups. 
According to these data, none of these abnormalities in bone except 
bone volume are influenced by success or failure of the renal transplants. 
This is a generalization that must be documented in carefully controlled 
prospective studies in which detailed analysis of renal function are 
correlated with bone changes detem1ined by kinetic studies on serial 
bone biopsies. 
Reduced bone volume, increased resorption volumes and decreased 
volume: surface ratios are the most significant abnormalities in bone 
of transplant patients. From a morphologic standpoint, bone of trans-
plant patients with the most severe reductions in volume is quite unlike 
bone seen in other forms of metabolic bone disease. The most striking 
feature of trabecular bone in these 'i'ansplant patients is the extent to 
which tunneling resorption has hollowed out the bone trabeculae and 
decreased the V: S ratio while markedly increasing the resorptive 
volume. It is apparent that, for a gh'en decrease in trabecular volume, 
tunneling resorption will result in at least twice the increase in trabec-
ular surface that resorption from a single surface could produce. ~lor· 
phologically, this type of tunneling resorption of trabecular bone is 
similar to cortical oone remodeling units described by La CroixP 
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Accordingly, spaces formed in trabecular bone by tunneling resorption 
would be expected to fill in with new bone, once the resorptive phase 
of remodeling were completeP 
Tunneling resorption is a characteristic feature of primary hyper-
parathyroidism 13 and secondary hyperparathyroidism in renal osteo-
d),strophyY·15 In primary hyperparathyroidism, the spaces are filled 
with fibrous marrow in early stages, and there is a moderate amount of 
new bone formation in later stages. Total skeletal volume is markedly 
reducedY In short- or long-standing renal osteodystrophy in dialyzed 
and n9ndialyzed patients, intratrabecular spaces occur, but they contain 
both osteoclasts (resorptive phase) and osteoblasts (bone-fomling 
phase), and the total trabecular bone volume is characteristically normal 
or increased.1 
Less severe tunneling resorption is also seen in osteoporosis associated 
with hyperthyroidism, again with both osteoblasts and osteoclasts \'dthin 
the spaces. 16•17 In the resorptive phase of disuse osteoporosis, sit(liJar 
tunneling resorption of trabeculae is seen. This is followed by renewed 
bone formation within the resorptiye spaces once the bone is remo-
bilizedY Increased resorptive activity of any kind is said to be rare in 
senile and idiopathic osteoporosis,18 although in our experience it is 
possible to see mild degrees of increased resorption, including occasional 
small resorption tunnels containing either osteoclasts or osteoblasts, in 
these conditions also. In steroid-induced osteoporosis, resorptive spaces 
are rarely seen.19 In this condition the smooth trabeculae are covered 
by normal-appearing osteoblasts. Thus, in comparison to other condi-
tions characterized by reduced bone \'olume and volume: surface ratios, 
severely affected bone in transplant patients has a markedly increased 
resorption volume in proportion to trabecular volume, there is no 
marrow fibrosis, and the osteoblastic phase of the remodeling proeess 
mllst be partially suppressed since bone volume falls. In most of the 
patients, some bone formation can be shown by the frequent occurrence 
of osteoid seams and elevated osteoid indices. However, unlike the 
situation in dialyzed and non dialyzed patients, the osteoid seams are 
quite thin. The elevations of osteoid index in transplant patients thus· 
seem to represent a mineralization defect which is exaggerated by the 
markedly reduced bone volume characteristic of these patients. 
The data of this study indicate that the critical period is the first year 
after transplantation. Resorption volume is maximal during the first 6 
months follOWing renal transplantation. The V: S ratio fans sharply dur-
ing the first year. The bone volume begins to fall during the first year 
and declines progressively for as long as 96 months. During the first year 
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after transplantation, hypercalcemia is frequent and is associated with 
parathyroid hyperplasia. lO These clinical and biochemical studies sup-
port the morphologic data presented here and suggest that parathor-
mone-induced bone resorption is a primary cause of declining bone 
volumes in transplant patients. Studies of bone volume changes in long-
term dialysis patients suggested that lower serum phosphate levels 
might contribute to a reduced bone volume, either through loss of sup-
pression of parathormone-induced bone resorption or by loss of stimula-
tion to bone formation. l In the present study patients with poor renal 
function (and presumably higher serum phosphate levels) had some-
what lower bone volumes. These results might be explained by in-
creased steroid-induced suppression of the synthetic phase of bone 
remodeling, :?O,21 since the patients with rejection receive higher doses 
of steroids. 
Similar mechanisms presumably explain the slow recovery of V:S 
ratios and the continuing decline of bone volume in long-term transplant 
patients. Grade 4 resorptive lesions persist in these patients, as does 
clinical evidence for hyperparathyroidism.10 The continued use of ster-
oids could be anticipated to perpetuate suppression of bone formation 
which in the face of continued excessive resorption would result in a 
declining bone volume, Prospective studies correlating steroid dosage, 
renal function, serum mineral levels, and parathormone levels with 
serial quantitative bone biopsies or densitometric studies are needed to 
resolve these questions. 
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